
BRD9539
CAS No. 1374601-41-8
BRD9539( —— )
Catalog No. M20714 CAS No. 1374601-41-8
BRD9539 is an inhibitor of euchromatin histone methyltransferase 2 (EHMT2) also known as G9a with an IC50 value of 6.3 μM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 27 | In Stock |
![]() ![]() |
5MG | 42 | In Stock |
![]() ![]() |
10MG | 71 | In Stock |
![]() ![]() |
25MG | 119 | In Stock |
![]() ![]() |
50MG | 176 | In Stock |
![]() ![]() |
100MG | 259 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameBRD9539
-
NoteResearch use only, not for human use.
-
Brief DescriptionBRD9539 is an inhibitor of euchromatin histone methyltransferase 2 (EHMT2) also known as G9a with an IC50 value of 6.3 μM.
-
DescriptionBRD9539 is an inhibitor of euchromatin histone methyltransferase 2 (EHMT2) also known as G9a with an IC50 value of 6.3 μM.
-
In VitroBRD9539 decreases ATP levels in a dose-dependent manner in HeLa cells.BRD9539 is a more potent biochemical inhibitor than its methyl-ester analogue BRD4770, with 20% remaining G9a activity compared to 45% of BRD4770 at screening concentration. However, BRD9539 has no activity in cell-based assays, presumably due to impaired cell permeability compared to that of BRD4770. In addition, the activities of 16 other chromatin-modifying enzymes and 100 kinases involved in cell-cycle regulation and cancer cell biology are tested for activity in the presence of 5 or 10 μM BRD9539; no activity is seen in any of these assays.
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorG9a
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1374601-41-8
-
Formula Weight399.44
-
Molecular FormulaC24H21N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:35 mg/mL (87.62 mM)
-
SMILESOC(=O)c1ccc2n(CCCc3ccccc3)c(NC(=O)c3ccccc3)nc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yuan Y Wang Q Paulk J et al. A Small-Molecule Probe of the Histone Methyltransferase G9a Induces Cellular Senescence in Pancreatic Adenocarcinoma[J]. ACS Chemical Biology 2012 7(7):1152-1157.
molnova catalog



related products
-
Tazemetostat hydrobr...
Tazemetostat hydrobromide is a potent and selective EZH2 inhibitor.
-
QC-6352
QC-6352 is a potent and selective KDM4 family inhibitor.
-
T-3775440
T-3775440 is a novel potent, selecitve, irreversible LSD1 inhibitor with IC50 of 2.1 nM.